Integrative transcriptome-wide analysis of atopic dermatitis for drug repositioning.

Area of Science:

• Genetics and Genomics
• Dermatology
• Computational Biology

Background:

• Atopic dermatitis (AD) is a prevalent inflammatory skin condition significantly affecting patient quality of life.
• Understanding the genetic underpinnings of AD is crucial for developing effective treatments.

Purpose of the Study:

• To identify novel genetic associations and susceptibility genes for atopic dermatitis using integrated genomic approaches.
• To explore potential therapeutic targets by analyzing enriched perturbations from combined TWAS and meta-analysis data.

Main Methods:

• Conducted transcriptome-wide association studies (TWAS) to analyze transcriptomic and genomic features of AD.
• Performed transcriptome meta-analysis integrating five public studies to identify additional AD susceptibility genes.
• Utilized connectivity mapping on integrated results to identify and analyze robustly enriched perturbations.

Main Results:

• TWAS identified significant associations with 31 expression quantitative loci and 25 genes, including 4 novel AD-associated genes.
• Transcriptome meta-analysis revealed 5 additional novel susceptibility genes for AD.
• Integrative analysis identified robustly enriched perturbations with potential therapeutic relevance.

Conclusions:

• This research presents the first integrative study combining TWAS and transcriptome meta-analysis for atopic dermatitis.
• The findings provide a comprehensive understanding of AD's pathophysiologic mechanisms.
• Identified genes and perturbations suggest potential novel drug candidates for AD treatment.